| Severe COVID-19 infection | Not severe COVID-19 infection | ||||
---|---|---|---|---|---|---|
 | Ciclesonide (n = 118) | No ciclesonide (n = 34) | p value | Ciclesonide (n = 66) | No ciclesonide (n = 51) | p value |
Initiated supplemental oxygen after admission | Not applicable | 38 (57.6%) | 17 (33.3%) | 0.0095 | ||
Mechanical ventilation | 18 (15.3%) | 11 (32.4%) | 0.0259 | 5 (7.6%) | 1 (2.0%) | 0.2301 |
In-hospital mortality | 8 (6.8%) | 17 (50.0%) | < 0.0001 | 6 (9.1%) | 3 (5.9%) | 0.7296 |
 | High Shang’s CSS risk | Low Shang’s CSS risk | ||||
 | Ciclesonide (n = 61) | No ciclesonide (n = 37) | p value | Ciclesonide (n = 118) | No ciclesonide (n = 41) | p value |
Initiated supplemental oxygen after admission | 9 (14.8%) | 8(21.6%) | 0.3865 | 27 (22.9%) | 9 (22.0%) | 0.9027 |
Mechanical ventilation | 9 (14.8%) | 8 (21.6%) | 0.3865 | 14 (11.9%) | 4 (9.8%) | > 0.9999 |
In-hospital mortality | 10 (16.4%) | 16 (43.2%) | 0.0037 | 2 (1.7%) | 2 (4.9%) | 0.2738 |